Jazz Pharmaceuticals announced a strategic collaboration with Life Science Cares to drive social impact through employee volunteerism in the U.S. This partnership reinforces Jazz‘s commitment to supporting the communities in which employees work and live. Life Science Cares is a collective effort to activate the financial and human capital of the life sciences industry across several regions in the U.S.to disrupt the cycle of poverty and inequality in those communities. With hubs around Jazz’s U.S. offices in Palo Alto, Philadelphia and San Diego, Life Science Cares will help enable Jazz’s goals to harness the passion of its employees to make a meaningful difference in their communities. The U.S. has the highest overall poverty rate among developed nations. Thirty-four million people in the U.S. are food insecure and 1 in 500 Americans is unhoused. Life Science Cares was founded in 2016 by life science leaders committed to harnessing the industry’s resources to address these problems.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JAZZ:
- Jazz Pharmaceuticals price target lowered to $200 from $230 at Barclays
- Jazz Pharmaceuticals price target lowered to $200 from $225 at TD Cowen
- Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance
- Jazz Pharmaceuticals sees 2024 non-GAAP EPS $18.15-$19.35, consensus $18.93
- Jazz Pharmaceuticals reports Q1 non-GAAP EPS $2.68, consensus $4.18
Questions or Comments about the article? Write to editor@tipranks.com